During the past 3 years, the average EBITDA Per Share Growth Rate was 5.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 28.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 44.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Scorpius Holdings was 66.20% per year. The lowest was -27.00% per year. And the median was 35.80% per year.
Competitive Comparison of Scorpius Holdings's 3-Year EBITDA Growth Rate
For the Biotechnology subindustry, Scorpius Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scorpius Holdings's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Scorpius Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Scorpius Holdings's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Scorpius Holdings 3-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Scorpius Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Scorpius Holdings (Scorpius Holdings) Business Description
NightHawk Biosciences Inc is a commercial-stage company with a fully integrated ecosystem to accelerate the discovery and development of novel therapies that arm the immune system. By leveraging its proprietary platforms, the company is advancing its first-in-class product portfolio with a focus on cancer and inflammatory and infectious diseases. Its current pipeline has categories: Oncology, immunology and molecular biology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SCPX has been successfully added to your